tiprankstipranks
AbbVie (DE:4AB)
XETRA:4AB
Holding DE:4AB?
Track your performance easily

AbbVie (4AB) Technical Analysis

19 Followers

Summary of all the Indicators

Overall Consensus
Buy
15Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
AbbVie’s (4AB) Moving Averages Convergence Divergence (MACD) indicator is 0.24, suggesting AbbVie is a Sell.
AbbVie’s (4AB) 20-Day exponential moving average is 169.22, while AbbVie’s (4AB) share price is €174.74, making it a Buy.
AbbVie’s (4AB) 50-Day exponential moving average is 170.16, while AbbVie’s (4AB) share price is €174.74, making it a Buy.

AbbVie (4AB) Pivot Points

Jan 03, 2025, 03:45 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
167.36
168.40
169.22
170.26
171.08
172.12
172.94
Fibonacci
168.40
169.11
169.55
170.26
170.97
171.41
172.12
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (4AB) Moving Averages

Jan 03, 2025, 03:45 PM
Period
Simple
Exponential
MA5
170.80Buy
171.05Buy
MA10
169.25Buy
169.83Buy
MA20
168.32Buy
169.22Buy
MA50
171.29Buy
170.16Buy
MA100
172.96Buy
169.62Buy
MA200
163.80Buy
164.11Buy
AbbVie’s (4AB) 10-Day exponential moving average is 169.83, while AbbVie’s (4AB) share price is €174.74, making it a Buy.
AbbVie’s (4AB) 100-Day exponential moving average is 169.62, while AbbVie’s (4AB) share price is €174.74, making it a Buy.
AbbVie’s (4AB) stock price is €174.74 and AbbVie’s (4AB) 50-day simple moving average is 171.29, creating a Buy signal.
AbbVie’s (4AB) stock price is €174.74 and AbbVie’s (4AB) 100-day simple moving average is 172.96, creating a Buy signal.
AbbVie’s (4AB) stock price is €174.74 and AbbVie’s (4AB) 200-day simple moving average is 163.80, creating a Buy signal.

AbbVie (4AB) Technical Indicators

Jan 03, 2025, 03:45 PM
Name
Value
Implied Action
RSI (14)
59.37
Neutral
STOCH (9,6)
85.45
Sell
STOCHRSI (14)
85.48
Sell
MACD (12,26)
0.24
Sell
ADX (14)
11.03
Buy
Williams %R
-0.52
Sell
CCI (14)
145.86
Sell
ATR (14)
3.20
-
Ultimate Oscillator
66.13
Neutral
ROC
3.59
Buy
AbbVie’s (4AB) Relative Strength Index (RSI) is 59.37, creating a Neutral signal.
AbbVie’s (4AB) Trend Strength Indicator (ADX) is 11.03, creating a Buy signal.
AbbVie’s (4AB) Commodity Channel Index (CCI) is 145.86, creating a Sell signal.
AbbVie’s (4AB) Price Rate of Change (ROC) is 3.59, creating a Buy signal.

FAQ

Is 4AB a Buy, Hold, or Sell?
Based on 4AB’s technical indicators, 4AB is a Buy.
    What is 4AB’s RSI (14)?
    4AB’s RSI (14) is 59.37, which suggests 4AB is a Neutral.
      What is 4AB’s MACD?
      4AB’s MACD is 0.24, which suggests 4AB is a Sell.
        What is 4AB’s 5-day moving average?
        4AB’s 5-day moving average is 170.80, which suggests 4AB is a Buy.
          What is 4AB’s 20-day moving average?
          4AB 20-day moving average is 168.32, which suggests 4AB is a Buy.
            What is 4AB’s 50-day moving average?
            4AB’s 50-day moving average is 171.29, which suggests 4AB is a Buy.
              What is 4AB’s 200-day moving average?
              4AB’s 200-day moving average is 163.80, which suggests 4AB is a Buy.
                What is 4AB’s Williams % R (14)?
                4AB’s Williams % R (14) is -0.52, which suggests 4AB is a Sell.
                  What is 4AB’s CCI (14)?
                  4AB’s CCI (14) is 145.86, which suggests 4AB is a Sell.
                    What is the share price of AbbVie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis